These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26901531)

  • 1. The novel tumor suppressor AIRAPL regulates IGF1R proteostasis.
    Osorio FG; Freije JM; López-Otín C
    Cell Cycle; 2016; 15(7):873-4. PubMed ID: 26901531
    [No Abstract]   [Full Text] [Related]  

  • 2. Loss of the proteostasis factor AIRAPL causes myeloid transformation by deregulating IGF-1 signaling.
    Osorio FG; Soria-Valles C; Santiago-Fernández O; Bernal T; Mittelbrunn M; Colado E; Rodríguez F; Bonzon-Kulichenko E; Vázquez J; Porta-de-la-Riva M; Cerón J; Fueyo A; Li J; Green AR; Freije JM; López-Otín C
    Nat Med; 2016 Jan; 22(1):91-6. PubMed ID: 26692333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells.
    Schedlich LJ; Yenson VM; Baxter RC
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):56-64. PubMed ID: 23831640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGFBP7 binds to the IGF-1 receptor and blocks its activation by insulin-like growth factors.
    Evdokimova V; Tognon CE; Benatar T; Yang W; Krutikov K; Pollak M; Sorensen PH; Seth A
    Sci Signal; 2012 Dec; 5(255):ra92. PubMed ID: 23250396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tyrosine kinase signalling in breast cancer: insulin-like growth factors and their receptors in breast cancer.
    Zhang X; Yee D
    Breast Cancer Res; 2000; 2(3):170-5. PubMed ID: 11250706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasis.
    O'Neill BT; Lee KY; Klaus K; Softic S; Krumpoch MT; Fentz J; Stanford KI; Robinson MM; Cai W; Kleinridders A; Pereira RO; Hirshman MF; Abel ED; Accili D; Goodyear LJ; Nair KS; Kahn CR
    J Clin Invest; 2016 Sep; 126(9):3433-46. PubMed ID: 27525440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression difference of insulin-like growth factor 1 receptor in breast cancers with or without diabetes.
    Xin C; Jing D; Jie T; Wu-Xia L; Meng Q; Ji-Yan L
    J Cancer Res Ther; 2015; 11(2):295-9. PubMed ID: 26148588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-Like Growth Factor and SLC12A7 Dysregulation: A Novel Signaling Hallmark of Non-Functional Adrenocortical Carcinoma.
    Brown TC; Nicolson NG; Stenman A; Juhlin CC; Gibson CE; Callender GG; Korah R; Carling T
    J Am Coll Surg; 2019 Sep; 229(3):305-315. PubMed ID: 31034883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer.
    Werner H
    Oncogene; 2012 May; 31(22):2703-14. PubMed ID: 21963847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of binding of insulin-like growth factor (IGF)-I and IGF-II analogues to the type 1 IGF receptor determined by BIAcore analysis.
    Forbes BE; Hartfield PJ; McNeil KA; Surinya KH; Milner SJ; Cosgrove LJ; Wallace JC
    Eur J Biochem; 2002 Feb; 269(3):961-8. PubMed ID: 11846798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin impairs the insulin-like growth factor-1 system and causes insulin-like growth factor-1 resistance in cardiomyocytes.
    Fabbi P; Spallarossa P; Garibaldi S; Barisione C; Mura M; Altieri P; Rebesco B; Monti MG; Canepa M; Ghigliotti G; Brunelli C; Ameri P
    PLoS One; 2015; 10(5):e0124643. PubMed ID: 25955698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ginsenoside F1 promotes angiogenesis by activating the IGF-1/IGF1R pathway.
    Zhang J; Liu M; Huang M; Chen M; Zhang D; Luo L; Ye G; Deng L; Peng Y; Wu X; Liu G; Ye W; Zhang D
    Pharmacol Res; 2019 Jun; 144():292-305. PubMed ID: 31048033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy.
    Tognon CE; Sorensen PH
    Expert Opin Ther Targets; 2012 Jan; 16(1):33-48. PubMed ID: 22239439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r).
    Liu JP; Baker J; Perkins AS; Robertson EJ; Efstratiadis A
    Cell; 1993 Oct; 75(1):59-72. PubMed ID: 8402901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF1/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells.
    Li Z; Pan W; Shen Y; Chen Z; Zhang L; Zhang Y; Luo Q; Ying X
    Cell Cycle; 2018; 17(10):1212-1219. PubMed ID: 29886785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling.
    Cedano Prieto DM; Cheng Y; Chang CC; Yu J; Takada YK; Takada Y
    PLoS One; 2017; 12(9):e0184285. PubMed ID: 28873464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer.
    Blanquart C; Boute N; Lacasa D; Issad T
    Mol Pharmacol; 2005 Sep; 68(3):885-94. PubMed ID: 15976035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. InsR/IGF1R Pathway Mediates Resistance to EGFR Inhibitors in Glioblastoma.
    Ma Y; Tang N; Thompson RC; Mobley BC; Clark SW; Sarkaria JN; Wang J
    Clin Cancer Res; 2016 Apr; 22(7):1767-76. PubMed ID: 26561558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crosstalk between insulin-like growth factor (IGF) receptor and integrins through direct integrin binding to IGF1.
    Takada Y; Takada YK; Fujita M
    Cytokine Growth Factor Rev; 2017 Apr; 34():67-72. PubMed ID: 28190785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.